Caspase-2 Inhibition May Raise Age-Related Liver Cancer Risk
Deleting Caspase-2, once considered protective against fatty liver disease, disrupts liver cell quality control, leading to polyploidy, chronic inflammation and fibrosis, and markedly increasing age-related liver cancer risk in mice.